Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypersensitivity pneumonitis induced by nalidixic acid.

M Dan, D Aderka, M Topilsky

    Archives of Internal Medicine
    |July 1, 1986
    PubMed
    Summary

    Nalidixic acid can cause interstitial pneumonitis, a rare lung condition. This hypersensitivity reaction is identified through eosinophilia and specific immune tests, confirming a link between the drug and lung disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ambidextrous approach of silver decorated polydopamine-zinc oxide nanohybrid for long-lasting ROS generation and efficient drug delivery in tumor therapy.

    International journal of biological macromolecules·2025
    Same author

    Chronic high-level multidrug-resistant Campylobacter coli enterocolitis in an agammaglobulinemia patient: Oral gentamicin efficacy.

    Medecine et maladies infectieuses·2020
    Same author

    First operation in SPIDER and the path to complete MITICA.

    The Review of scientific instruments·2020
    Same author

    Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2019
    Same author

    Possible synergistic effect of apoE and LRP1 genotypes on metabolic syndrome development in Serbian patients.

    Molecular biology reports·2019
    Same author

    Prevalence of anti-hepatitis B surface antibodies among children and adolescents vaccinated in infancy and effect of booster dose administered within a pilot study.

    Epidemiology and infection·2017

    Area of Science:

    • Pulmonary Medicine
    • Clinical Pharmacology
    • Immunology

    Background:

    • Nalidixic acid is an antibiotic used to treat urinary tract infections.
    • Interstitial pneumonitis is a group of lung diseases affecting the interstitium.
    • Drug-induced lung disease is a known but often underdiagnosed complication of pharmacotherapy.

    Observation:

    • A patient developed interstitial pneumonitis one week after starting nalidixic acid therapy.
    • Peripheral blood and bronchoalveolar lavage fluid showed increased eosinophil counts.
    • A migration inhibitory factor test was positive for nalidixic acid.

    Findings:

    • A causal association was established between nalidixic acid and the patient's interstitial pneumonitis.
    • The diagnosis was supported by temporal relationship, eosinophilia, positive immunological tests, and exclusion of other causes.

    Related Experiment Videos

  • This represents the first reported case of pulmonary hypersensitivity to nalidixic acid.

    • Implications:

    • Highlights the potential for nalidixic acid to induce severe pulmonary hypersensitivity reactions.
    • Emphasizes the importance of considering drug-induced lung disease in patients presenting with unexplained pneumonitis.
    • Suggests the need for vigilance and diagnostic testing for hypersensitivity reactions to quinolone antibiotics.